Epilepsy Research
Volume 30, Issue 3 , Pages 241-246 , May 1998

Hyponatremia induced by oxcarbazepine in children

Received 27 November 1997 ,Revised 5 February 1998 ,Accepted 23 February 1998.

References 

  1. Bjornson I, Johannessen SI. Hyponatremia in patients with epilepsy being treated with carbamazepine or oxcarbazepine. Epilepsia. 1997;38(Suppl 3):72
  2. Dam M. Practical aspects of oxcarbazepine treatment. Epilepsia. 1994;35(Suppl 3):S23–S25
  3. Dam M, Ekberg R, Loyning Y, Waltimo O, Jakobsen K. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. Epilepsy Res. 1989;3:70–76
  4. Friis ML, Kristensen O, Boas J, Dalby M, Deth SH, Gram L, et al. Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment. Acta Neurol Scand. 1993;87:224–227
  5. Guerreiro MM, Vigonius U, Pohlmann H, DeManreza MLG, Fejerman N, Antoniuk SA, et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res. 1997;27:205–213
  6. Houtkooper MA, Lammertsma A, Meyer JWA, Goedhart DM, Meinardi H, Van Oorschot CAEH, et al. Oxcarbazepine (GP 47.680): A possible alternative to carbamazepine?. Epilepsia. 1987;28:693–698
  7. Huuskonen UEJ, Isojärvi JIT. Antiepileptic drugs and serum sodium (Abstract). Epilepsia. 1997;38(Suppl 8):89
  8. Johannessen AC, Nielsen OA. Hyponatremia induced by oxcarbazepine. Epilepsy Res. 1987;1:155–156
  9. Juergens U. HPLC analysis of antiepileptic drugs in blood samples: microbore separation of fourteen compounds. J Chromatogr. 1987;10:507–532
  10. Kallf R, Houtkooper MA, Meyer JWA, Goedhart DM, Augusteijin R, Meinardi H. Carbamazepine and serum sodium levels. Epilepsia. 1984;25:390–397
  11. Koivikko MJ, Valikangas SL. Hyponatraemia during carbamazepine therapy in children. Neuropediatrics. 1983;14(2):93–96
  12. Motte J, Arzimanoglu AA, Billard C, Boidein F, Boulloche J, Carriere JP, et al. Open study of tolerability of oxcarbazepine in children (Abstract). Epilepsia. 1995;36(Suppl 3):S118
  13. Nielsen OA, Johannessen AC, Bardrum B. Oxcarbazepine-induced hyponatremia, a cross-sectional study. Epilepsy Res. 1988;2:269–271
  14. Norusis, M.J., 1997. SPSS for Windows. Chicago.
  15. Pendlebury SC, Moses DK, Eadie MJ. Hyponatraemia during oxcarbazepine therapy. Hum Toxicol. 1989;8(5):337–344
  16. Rambeck B, Sälke-Treumann A, May T, Boenigk HE. Valproic acid-induced carbamazepine-10,11-epoxide toxicity in children and adolescents. Eur Neurol. 1990;30(2):79–83
  17. Reinikainen KJ, Keränen T, Halonen T, Komulainen H, Riekkinen PJ. Comparison of oxcarbazepine and carbamazepine: a double-blind study. Epilepsy Res. 1987;1:284–289
  18. Rosendahl L, Friis ML. Metabolic encephalopathy: oxcarbazepine (Trileptal)-induced hyponatremia. Ugeskr Laeger. 1991;153(38):2637–2638
  19. Steinhoff BJ, Stoll KD, Stodieck SRG, Paulus W. Hyponatremic coma under oxcarbazepine therapy. Epilepsy Res. 1992;11:67–70
  20. Thomas, L., 1992. Labor und Diagnose. Die Medizinische Verlagsgesellschaft, Marburg.
  21. Van Amelsvoort T, Bakshi R, Devaux CB, Schwabe S. Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review. Epilepsia. 1994;35(1):181–188
  22. Van Parys JAP, Meinardi H. Survey of 260 epileptic patients treated with oxcarbazepine (Trileptal®) on a named-patient basis. Epilepsy Res. 1994;19:79–85

PII: S0920-1211(98)00012-6

Epilepsy Research
Volume 30, Issue 3 , Pages 241-246 , May 1998

Article Tools

* Image Usage & Resolution